Incidence and diagnosis of ventilator-associated tracheobronchitis in the intensive care unit: an international online survey

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorRODRIGUEZ, Alejandro
dc.contributor.authorPOVOA, Pedro
dc.contributor.authorNSEIR, Saad
dc.contributor.authorSALLUH, Jorge
dc.contributor.authorCURCIO, Daniel
dc.contributor.authorMARTIN-LOECHES, Ignacio
dc.contributor.groupauthorTAVeM Grp Investigators
dc.contributor.groupauthorHAJJAR, Ludhmila
dc.contributor.groupauthorFERREIRA, Cesar Biselli
dc.contributor.groupauthorSÁ, Luiz Marcelo
dc.contributor.groupauthorTANIGUCHI, Leandro Utino
dc.contributor.groupauthorRANZANI, Otavio
dc.contributor.groupauthorPARK, Marcelo
dc.date.accessioned2019-08-20T14:43:17Z
dc.date.available2019-08-20T14:43:17Z
dc.date.issued2014
dc.description.abstractIntroduction: Several aspects of ventilator-associated tracheobronchitis (VAT)-including diagnostic criteria, overlap with ventilator-associated pneumonia (VAP), and appropriate treatment regimens-remain poorly defined. The objectives of this study were to survey reported practices in the clinical and microbiological diagnosis of VAT and to evaluate perceptions of the impact of VAT on patient outcomes. Methods: We developed a questionnaire consisting of (a) characteristics of the respondent, the ICU, and hospital; (b) current clinical and microbiological diagnostic approach; (c) empirical antibiotic therapy; and (d) the perception of physicians regarding the clinical impact of VAT and its implications. Results: A total of 288 ICUs from 16 different countries answered the survey: 147 (51%) from the Latin American (LA) group and 141 (49%) from Spain, Portugal, and France (SPF group). The majority of respondents (n = 228; 79.2%) reported making the diagnosis of VAT based on clinical and microbiological criteria, and 40 (13.9%) by clinical criteria alone. Approximately half (50.3%) of the respondents agreed that patients should receive antibiotics for the treatment of VAT. Out of all respondents, 269 (93.4%) assume that a VAT episode increases ICU length of stay, and this perception is greater in the LA group (97.3%) than in the SPF group (89.4%, P < 0.05). Half of the physicians considered that VAT increases the risk of mortality, and this perception is again greater in the LA group (58.5% versus 41.1%, P < 0.05). Conclusions: Given the possible high incidence of VAT and the perception of its importance as a risk factor for VAP and mortality, a large multicenter international prospective study would be helpful to validate a consensual definition of VAT, determine its incidence, and delineate its impact on subsequent VAP occurrence.eng
dc.description.indexMEDLINEeng
dc.description.sponsorshipSEMICYUC (Sociedad Espanola de Medicina Intensiva, Critica y Unidades Coronaria)
dc.description.sponsorshipFEPIMCTI (Federacion Panamericana e Iberica de Sociedades de Medicina Critica y Terapia Intensiva)
dc.identifier.citationCRITICAL CARE, v.18, n.1, article ID R32, 11p, 2014
dc.identifier.doi10.1186/cc13725
dc.identifier.eissn1364-8535
dc.identifier.issn1466-609X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/33049
dc.language.isoeng
dc.publisherBIOMED CENTRAL LTDeng
dc.relation.ispartofCritical Care
dc.rightsopenAccesseng
dc.rights.holderCopyright BIOMED CENTRAL LTDeng
dc.subject.otherattributable mortalityeng
dc.subject.otherrandomized preventioneng
dc.subject.otheracquired pneumoniaeng
dc.subject.othermulticentereng
dc.subject.wosCritical Care Medicineeng
dc.titleIncidence and diagnosis of ventilator-associated tracheobronchitis in the intensive care unit: an international online surveyeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryArgentina
hcfmusp.affiliation.countryEspanha
hcfmusp.affiliation.countryPortugal
hcfmusp.affiliation.countryFrança
hcfmusp.affiliation.countryisoes
hcfmusp.affiliation.countryisopt
hcfmusp.affiliation.countryisofr
hcfmusp.affiliation.countryisoar
hcfmusp.author.externalRODRIGUEZ, Alejandro:Hosp Joan XXIII Crit Care Dept IISPV URV CIBERES, Tarragona 43007, Spain
hcfmusp.author.externalPOVOA, Pedro:Sao Francisco Xavier Hosp, Polyvalent Intens Care Unit, P-1495005 Lisbon, Portugal
hcfmusp.author.externalNSEIR, Saad:CHU Lille, F-59037 Lille, France
hcfmusp.author.externalSALLUH, Jorge:Inst Nacl Canc Praca Cruz Vermelha, Inst Res & Educ, Postgrad Program, BR-20230130 Rio De Janeiro, Brazil
hcfmusp.author.externalCURCIO, Daniel:Hosp Municipal Chivilcoy, RA-6620 Buenos Aires, DF, Argentina
hcfmusp.author.externalMARTIN-LOECHES, Ignacio:Hosp Sabadell Inst Univ UAB, Crit Care Ctr, Corp Sanitaria & Univ Parc Tauli, Ciber Enfermedades Resp, Barcelona 08208, Spain
hcfmusp.citation.scopus27
hcfmusp.description.articlenumberR32
hcfmusp.description.issue1
hcfmusp.description.volume18
hcfmusp.origemWOS
hcfmusp.origem.pubmed24521533
hcfmusp.origem.scopus2-s2.0-84897461320
hcfmusp.origem.wosWOS:000338991900069
hcfmusp.publisher.cityLONDONeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceCraven DE, 2013, AM J MED, V126, P542, DOI 10.1016/j.amjmed.2012.12.012eng
hcfmusp.relation.referenceCraven DE, 2008, CRIT CARE, V12, DOI 10.1186/cc6912eng
hcfmusp.relation.referenceGARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3eng
hcfmusp.relation.referenceGrgurich PE, 2013, CURR OPIN INFECT DIS, V26, P140, DOI 10.1097/QCO.0b013e32835ebbd0eng
hcfmusp.relation.referenceMalacarne P, 2008, CRIT CARE MED, V36, P1105, DOI 10.1097/CCM.0b013e318169ed30eng
hcfmusp.relation.referenceMandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159eng
hcfmusp.relation.referenceMartin-Loeches I, 2013, REANIMATION, V22, P231, DOI 10.1007/s13546-013-0678-7eng
hcfmusp.relation.referenceMartin-Loeches I, 2010, CLIN PULM MED, V17, P117eng
hcfmusp.relation.referenceMelsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1eng
hcfmusp.relation.referenceMelsen WG, 2011, CRIT CARE MED, V39, P2736, DOI 10.1097/CCM.0b013e3182281f33eng
hcfmusp.relation.referenceNseir S, 2008, CRIT CARE, V12, DOI 10.1186/cc6890eng
hcfmusp.relation.referencePalmer LB, 2008, CRIT CARE MED, V36, P2008, DOI 10.1097/CCM.0b013e31817c0f9eeng
hcfmusp.relation.referenceSelf WH, 2013, AM J EMERG MED, V31, P401, DOI 10.1016/j.ajem.2012.08.041eng
hcfmusp.relation.referenceTorres A, 2009, INTENS CARE MED, V35, P9, DOI 10.1007/s00134-008-1336-9eng
hcfmusp.scopus.lastupdate2024-05-10
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_RODRIGUEZ_Incidence_and_diagnosis_of_ventilatorassociated_tracheobronchitis_in_the_2014.PDF
Tamanho:
538.96 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/08
Artigos e Materiais de Revistas Científicas - LIM/09
Carregar mais